| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences, Inc. (GILD) has 11 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. GILD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.3K | $79.13M | -15,000 | |
| Other | 46.9K | $5.93M | - | |
| Other | 46.6K | $5.89M | - | |
| VP | 44.2K | $5.58M | - | |
| Other | 27.9K | $3.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Parsey Merdad52 | Chief Medical Officer | Sell | 2,000 | $83.83 | $167,660.00 | -2.0% | +9.6% | +32.4% | |
| Sep 12, 2024 | Mercier Johanna | Chief Commercial Officer | Sell | 29,357 | $83.78 | $2,459,576.75 | -14.7% | +11.1% | +37.7% | |
| Sep 12, 2024 | Parsey Merdad52 | Chief Medical Officer | Sale+OE | 21,246 | $84.50 | $1,795,287.00 | -17.2% | +11.1% | +37.7% | |
| Aug 28, 2024 | Mercier Johanna | Chief Commercial Officer | Sell | 9,513 | $78.03 | $742,299.39 | -8.3% | +16.3% | +43.3% | |
| Aug 13, 2024 | Mercier Johanna | Chief Commercial Officer | Sell | 5,490 | $73.98 | $406,150.20 | -4.6% | +31.2% | +62.4% | |
| Jul 1, 2024 | Parsey Merdad52 | Chief Medical Officer | Sell | 2,000 | $68.63 | $137,260.00 | -2.0% | +22.1% | +62.8% | |
| Jun 17, 2024 | Gilead Sciences, Inc.71 | 10% Owner | Buy | 179,500 | $0.00 | - | +16.5% | +29.4% | +68.0% | |
| Apr 2, 2024 | Gilead Sciences, Inc.71 | 10% Owner | Buy | 485,250 | $0.76 | $368,790.00 | +7.1% | -4.8% | +55.2% | |
| Apr 1, 2024 | Parsey Merdad52 | Chief Medical Officer | Sell | 2,000 | $72.96 | $145,920.00 | -2.0% | -5.8% | +52.7% | |
| Feb 29, 2024 | Parsey Merdad52 | Chief Medical Officer | Sell | 10,230 | $72.82 | $744,983.86 | -5.0% | -11.9% | +58.5% |